Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
China Molybdenum Co ( (HK:3993) ) has issued an announcement.
China Molybdenum Co, through its wholly-owned subsidiary Xizang Shmok, has invested RMB500 million in a limited partnership fund managed by Boyu Capital. This fund aims to achieve favorable capital returns by focusing on high-growth sectors such as technology, healthcare, and consumer products. The investment will be accounted for as financial assets at fair value through profit or loss, reflecting the company’s strategic move to leverage idle cash for potential growth opportunities in these sectors.
The most recent analyst rating on (HK:3993) stock is a Buy with a HK$21.00 price target. To see the full list of analyst forecasts on China Molybdenum Co stock, see the HK:3993 Stock Forecast page.
More about China Molybdenum Co
YTD Price Performance: 276.31%
Average Trading Volume: 50,359,306
Technical Sentiment Signal: Buy
Current Market Cap: HK$428.9B
Find detailed analytics on 3993 stock on TipRanks’ Stock Analysis page.